Brad Wrigley

Brad has over 20 years of experience as a manager, entrepreneur, investor and CEO having worked within the Government, MedTech and IT industries. These have included world-leading multinationals such as consultancy firm Accenture, IT giant Dell EMC and cloud services company Virtustream. Over the past few years Brad has focused on working with a number of start-ups and spin-out companies, helping them to bring their services and products to market.

Article's page

Prof Paul Cotter

Paul received his BSc and PhD in Microbiology from University College Cork. Paul is the Head of Food Biosciences at Teagasc and a Principal Investigator with the APC Microbiome Ireland and Vistamilk SFI Centres, as well as Food for Health Ireland. He also co-ordinates the EU H2020 Innovation Action relating to microbiomes and the food chain, MASTER. He is a molecular microbiologist, with a particular focus on the microbiology of foods, the food chain and of animals/humans. Paul’s laboratory at Teagasc were winners at the Irish Laboratory of the Year Awards on multiple occasions. He has also received awards from the Society for Applied Microbiology, ESCMID and FEMS, and heads the Applied Microbiology section within Faculty of 1000 (Biology), and was included in the Clarivate list of highly cited researchers for 2018 and 2019.

Article's page

Dr Marcus Claesson

Marcus received his BSc in Chemical Engineering & Physics and MSc in Bioinformatics at Chalmers University of Technology in Gothenburg. After a completed PhD on sequencing and comparative genomics of Lactobacillus species, he investigated the microbiota of aging as part of the ELDERMET project. Marcus is Principal Investigator at APC Microbiome Ireland, Programme Director of the MSc in Bioinformatics and Computational Biology at University College Cork, and Chair of the EU COST Action ML4Microbiome aiming to optimise the use of Machine Learning in microbiome science. With close to 20 years’ microbiome experience, his research interest includes the role of the microbiome in inflammatory bowel disease and associated methods development.

Article's page